190 related articles for article (PubMed ID: 11257479)
1. Therapeutic options in ocular myasthenia gravis.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
Neuromuscul Disord; 2001 Mar; 11(2):208-16. PubMed ID: 11257479
[TBL] [Abstract][Full Text] [Related]
2. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
3. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Ocular Myasthenia Gravis.
Cornblath WT
Asia Pac J Ophthalmol (Phila); 2018; 7(4):257-259. PubMed ID: 30044061
[TBL] [Abstract][Full Text] [Related]
5. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
6. Generalization after ocular onset in myasthenia gravis: a case series in Germany.
Li F; Hotter B; Swierzy M; Ismail M; Meisel A; Rückert JC
J Neurol; 2018 Dec; 265(12):2773-2782. PubMed ID: 30225725
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: signs, symptoms, diagnosis, immunology, and current therapy.
Scheife RT; Hills JR; Munsat TL
Pharmacotherapy; 1981; 1(1):39-54. PubMed ID: 6927602
[TBL] [Abstract][Full Text] [Related]
8. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Benatar M; Kaminski HJ;
Neurology; 2007 Jun; 68(24):2144-9. PubMed ID: 17460154
[TBL] [Abstract][Full Text] [Related]
9. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis.
Silvestri NJ; Wolfe GI
Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
[TBL] [Abstract][Full Text] [Related]
11. Ocular myasthenia: a protean disorder.
Weinberg DA; Lesser RL; Vollmer TL
Surv Ophthalmol; 1994; 39(3):169-210. PubMed ID: 7878520
[TBL] [Abstract][Full Text] [Related]
12. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.
Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy.
Sarnat HB; McGarry JD; Lewis JE
Neurology; 1977 Jun; 27(6):550-3. PubMed ID: 559263
[TBL] [Abstract][Full Text] [Related]
15. Ocular aspects of myasthenia gravis.
Barton JJ; Fouladvand M
Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatment of ocular myasthenia gravis.
Tackenberg B; Hemmer B; Oertel WH; Sommer N
BioDrugs; 2001; 15(6):369-78. PubMed ID: 11520248
[TBL] [Abstract][Full Text] [Related]
17. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
Sommer N; Melms A; Weller M; Dichgans J
Doc Ophthalmol; 1993; 84(4):309-33. PubMed ID: 8156854
[TBL] [Abstract][Full Text] [Related]
18. Medical and surgical treatment for ocular myasthenia.
Benatar M; Kaminski H
Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
[TBL] [Abstract][Full Text] [Related]
19. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
Mullaney P; Vajsar J; Smith R; Buncic JR
Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapies in myasthenia gravis.
Sanders DB; Evoli A
Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
